In This Issue, Volume 10, Issue 1
Year: 2019
Type: article
Abstract: ADVERTISEMENT RETURN TO ISSUEIn This IssueNEXTIn This Issue, Volume 10, Issue 1William C. K. PomerantzWilliam C. K. PomerantzMore by William C. K. Pomerantzhttp://orcid.org/0000-0002-0163-4078Cite this: ACS Med. Chem. Lett. 2019, 10, 1, 1Publication Date (Web):January 10, 2019Publication History Published online10 January 2019Published inissue 10 January 2019https://pubs.acs.org/doi/10.1021/acsmedchemlett.8b00650https://doi.org/10.1021/acsmedchemlett.8b00650in-briefACS PublicationsCopyright © 2019 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views545Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (645 KB) Get e-AlertscloseSUBJECTS:Agonists,Cancer,Cross coupling reaction,Peptides and proteins,Trifluoromethyl Get e-Alerts
Source: ACS Medicinal Chemistry Letters
Author: William C. K. Pomerantz
Language: English
Open Access status: green
OpenAlex ID: W4248953577